Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Non-cash Items (2017 - 2024)

Historic Non-cash Items for Rhythm Pharmaceuticals (RYTM) over the last 7 years, with Q4 2024 value amounting to $4.6 million.

  • Rhythm Pharmaceuticals' Non-cash Items rose 1632.96% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.6 million, marking a year-over-year increase of 1632.96%. This contributed to the annual value of $4.6 million for FY2024, which is 1632.96% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Non-cash Items of $4.6 million as of Q4 2024, which was up 1632.96% from $3.9 million recorded in Q4 2023.
  • In the past 5 years, Rhythm Pharmaceuticals' Non-cash Items ranged from a high of $74.0 million in Q4 2022 and a low of $3.2 million during Q4 2021
  • Over the past 4 years, Rhythm Pharmaceuticals' median Non-cash Items value was $4.3 million (recorded in 2023), while the average stood at $21.4 million.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Non-cash Items surged by 220224.02% in 2022 and then plummeted by 9468.06% in 2023.
  • Over the past 4 years, Rhythm Pharmaceuticals' Non-cash Items (Quarter) stood at $3.2 million in 2021, then soared by 2202.24% to $74.0 million in 2022, then plummeted by 94.68% to $3.9 million in 2023, then grew by 16.33% to $4.6 million in 2024.
  • Its Non-cash Items stands at $4.6 million for Q4 2024, versus $3.9 million for Q4 2023 and $74.0 million for Q4 2022.